MedTrace Logo

Intravenous Infusion of Lidocaine in Colonoscopy

NCT04439786 · Status: UNKNOWN · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2020-06-19

No results posted yet for this study

Summary

intravenous infusion of lidocaine significantly reduce fatigue and pain and improve the patients satisfaction after sedation for colonoscopy.

Conditions

  • Sedation

Interventions

DRUG

placebo

the control group will be given the same volume of saline.

DRUG

lidocaine

the experimental group will be given 1-1.5mg/kg lidocaine and then 2mg/kg/h

Sponsors & Collaborators

  • Shandong University

    lead OTHER

Principal Investigators

  • Shan dong China · Qilu Hospital of Shandong University

Study Design

Allocation
RANDOMIZED
Purpose
HEALTH_SERVICES_RESEARCH
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2020-07-01
Primary Completion
2020-12-01
Completion
2020-12-31

Countries

  • China

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04439786 on ClinicalTrials.gov